Open Access iconOpen Access

ARTICLE

crossmark

mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance

CHIWEN BU1,2, LIGANG ZHAO1, LISHAN WANG1, ZEQIAN YU1, JIAHUA ZHOU1,*

1 Department of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, China
2 School of Medicine, Southeast University, Nanjing, 210009, China

* Corresponding Author: JIAHUA ZHOU. Email: email

TSP_OR_29309.pdf

  • 901

    View

  • 435

    Download

  • 0

    Like

Share Link